These include: Given this market context, the opportunity for new therapeutic agents is considerable
The delayed gastric emptying caused by semaglutide may alter alcohol absorption and peak effects, potentially affecting how patients experience alcohol's impact
Learn why patients sometimes see delayed results and discover the essential role that lifestyle changes play in maximizing success
Most individuals report noticeable appetite suppression within the first two weeks of treatment, though maximum benefits typically emerge over 8-12 weeks as the body adapts to the medication
Non-diabetic users have increased from 8% of new users in 2020 to 34% in 2023
Companies that successfully address muscle preservation, reduce discontinuation-related regain, improve access and tolerability, or develop precision approaches for treatment-resistant patients will capture meaningful differentiation in what promises to become an increasingly commoditized market for first-generation GLP-1 agonists